oral squamous cell carcinoma
Oncology · 2016–2016
1decision
1medicine
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| cetuximab Recurrent and/or metastatic squamous cell carcinoma of the oral cavity in previously untreated patients with WHO performance status 0 or 1, in combination with… | Mar 2016 | Not recommended | input received Rare Cancers Australia |
Who spoke
Rare Cancers Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.